177 results
Page 2 of 9
6-K
EX-99.1
uztvj93zfoi qa
1 Aug 22
Current report (foreign)
4:48pm
6-K
EX-99.1
hmntv14e1xvzwf1s
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
EX-99.1
ceizff51cxzjdvfqfs70
7 Jul 22
Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway
8:30am
6-K
EX-99.1
rqjca6ih
31 Mar 22
Portage Biotech Provides Update on Clinical-Stage and Development Programs
8:00am
20-F/A
frocjfc kfy1
3 Mar 22
Annual report (foreign) (amended)
6:57pm
6-K
EX-99.1
87a1tugiwu
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.1
bzdpe2
25 Feb 22
Portage Biotech Announces Financial Results and Provides Business Update for Third Quarter of 2022 Fiscal Year
12:00am
6-K
EX-99.1
95to9eg
15 Feb 22
Portage Biotech Announces New Appointments to its Management Team and Board of Directors
8:00am
6-K
EX-99.1
bwss3dw7pgyoew10
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.1
1wygm8
23 Nov 21
Portage Biotech Announces Financial Results and Provides Business Update for Second Quarter of 2022 Fiscal Year
8:00am
6-K
h8ju kl2q2401
30 Aug 21
Current report (foreign)
5:21pm
6-K
EX-99.1
ud4 q82kcg
30 Aug 21
Portage Biotech Announces Results for First Quarter of 2022 Fiscal Year
8:00am
6-K
EX-99.1
i497o ghonf0oho88au4
12 Aug 21
Portage Biotech Issues Letter to Shareholders
10:01am